Zacks Research Has Bearish Estimate for Amgen Q1 Earnings
Amgen Inc. (NASDAQ:AMGN – Free Report) – Analysts at Zacks Research dropped their Q1 2025 earnings per share estimates for shares of Amgen in a research note issued to investors on Tuesday, February 25th. Zacks Research analyst R. Department now expects that the medical research company will post earnings per share of $4.17 for the […]
